Samuel Herschkowitz
Director/Board Member presso ACERUS PHARMACEUTICALS CORPORATION
Profilo
Samuel Herschkowitz was the founder of Serenity Pharmaceuticals Corp.
(founded in 2007), where he held the title of Chief Executive Officer & Chairman from 2007 to 2022.
He is also the founder of Serenity Pharmaceuticals LLC.
Currently, he holds the position of Vice Chairman at Acerus Pharmaceuticals Corp.
and is a Professor at NYU Langone Health.
In the past, he held the position of Chief Executive Officer & Director at Prospect Park Capital Corp.
from 2012 to 2020 and was the Chief Operating & Technical Officer, Director at Delcath Systems, Inc. from 1988 to 2007.
Dr. Herschkowitz received his undergraduate degree from Syracuse University in 1971 and his doctorate degree from the State University of New York at Downstate Medical Center in 1976.
Posizioni attive di Samuel Herschkowitz
| Società | Posizione | Inizio |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Director/Board Member | - |
NYU Langone Health
 NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Serenity Pharmaceuticals LLC
 Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a private company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Chief Executive Officer | - |
Precedenti posizioni note di Samuel Herschkowitz
| Società | Posizione | Fine |
|---|---|---|
Serenity Pharmaceuticals Corp.
 Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Chief Executive Officer | 01/02/2022 |
| PROSPECT PARK CAPITAL CORP. | Chief Executive Officer | 23/01/2020 |
| DELCATH SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 17/06/2007 |
Formazione di Samuel Herschkowitz
| Syracuse University | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| PROSPECT PARK CAPITAL CORP. | Finance |
| Aziende private | 4 |
|---|---|
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Technology Services |
Serenity Pharmaceuticals LLC
Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Acerus Pharmaceuticals Corp., Serenity Pharmaceuticals LLC is a private company that manufactures and distributes drugs. The company is based in Miami, FL. The company was founded by Samuel Herschkowitz. Samuel Herschkowitz has been the CEO since incorporation. Serenity Pharmaceuticals was acquired by Acerus Pharmaceuticals Corp. on March 07, 2022 for $44.30 million. | Health Technology |
- Borsa valori
- Insiders
- Samuel Herschkowitz
